Dr. Martens (LON:DOCS) Releases Quarterly Earnings Results

Dr. Martens (LON:DOCS) issued its earnings results on Tuesday. The company reported GBX 4.20 earnings per share (EPS) for the quarter, Digital Look Earnings reports. Dr. Martens had a net margin of 1.95% and a return on equity of 4.40%. The company had revenue of £764.90 million for the quarter.

Here are the key takeaways from Dr. Martens’ conference call:

• Adjusted PBT rose 61% to £55.0 million reported, helped by stronger gross margin, tight cost control, and better revenue quality. The company also said net bank debt fell by £25 million, reinforcing balance sheet progress.
• Americas and APAC improved materially, with full-price DTC sales up 14% in the Americas and 15% in APAC. Management said this reflects a successful shift toward higher-quality revenue and less markdown dependence.
• EMEA remains the main weak spot, with DTC down amid a promotional market and weak consumer backdrop, especially in the U.K. and Germany. Management said completing the full-price pivot there is a key FY2027 focus and will likely create a near-term revenue headwind.
• Wholesale returned to growth for the first time since FY2023, supported by stronger order books for autumn/winter 2026. The company highlighted successful multi-year partnerships with retailers as a driver of that momentum.
• The brand and product pivot is gaining traction, with new families like Lowell, Buzz and Zebzag rising from 3% to 9% of pairs sold, while shoes grew 19% and bags 15%. Dr. Martens also said its organization is now streamlined and its new store formats are delivering higher average selling prices.

Dr. Martens Trading Up 2.6%

Shares of DOCS stock opened at GBX 68.12 on Wednesday. Dr. Martens has a 12-month low of GBX 53.05 and a 12-month high of GBX 100.87. The company has a market capitalization of £658.85 million, a PE ratio of 40.07, a price-to-earnings-growth ratio of 6.40 and a beta of 0.22. The firm has a 50 day moving average price of GBX 63.95 and a two-hundred day moving average price of GBX 71.30. The company has a quick ratio of 1.13, a current ratio of 2.18 and a debt-to-equity ratio of 120.66.

Insider Buying and Selling at Dr. Martens

In other news, insider Ije Nwokori sold 204,051 shares of the stock in a transaction that occurred on Wednesday, April 15th. The stock was sold at an average price of GBX 66, for a total transaction of £134,673.66. Insiders purchased a total of 930 shares of company stock worth $59,984 in the last 90 days. 2.81% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. Royal Bank Of Canada reissued a “sector perform” rating on shares of Dr. Martens in a research report on Tuesday, February 3rd. Berenberg Bank cut their price objective on Dr. Martens from GBX 114 to GBX 110 and set a “buy” rating for the company in a research report on Tuesday. Two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of GBX 110.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history. It operates in over
60 countries and employs over 3,650 people worldwide. Its operations are split across both Direct-to-Consumer and
wholesale channels, and in addition to its world-renowned “1460” boot its product segments span shoes including the
1461 shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as well as a growing line of bags and
accessories.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.